Evidence map›Paper›PMID 40925996›Full record

ArticlePediatric research2026

Neonatal characteristics and neurodevelopmental phenotypes in congenital cytomegalovirus.

Sarah A Pollick, Fatima Noorulla, Gail Demmler Harrison, Samantha Nikirk, Jenna Hijawi, Julie Sturza, Megan H Pesch

Abstract read
In one paragraph

Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah A PollickDivision of Developmental and Behavioral Pediatrics, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.
Fatima NoorullaDivision of Developmental and Behavioral Pediatrics, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.
Gail Demmler HarrisonDivision of Pediatric Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Samantha NikirkDivision of Gastroenterology & Hepatology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Jenna HijawiUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Julie SturzaDepartment of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.
Megan H PeschDivision of Developmental and Behavioral Pediatrics, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA. pesch@umich.edu.

Funding

Valacyclovir Phase I TrialU54AI150225 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLIN, DAVID W · 2019 to 2024
$7.6M
Congenital cytomegalovirus: Infant developmental trajectories and parent experiencesK23HD108278 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PESCH, MEGAN H. · 2022 to 2025
$678k
NIAID NIH HHS U54 AI150225NICHD NIH HHS K23 HD108278
6 · The paper itself

Abstract

backgroundChildren with congenital cytomegalovirus (cCMV) have a wide spectrum of possible neurodevelopmental outcomes.

objectivesTo describe neurodevelopmental (ND) Phenotypes of children with cCMV based on medical, developmental, and behavioral outcomes in childhood, and examine whether birth characteristics were associated with ND Phenotype.

methodsCaregivers of children with cCMV (N = 242, child aged 12 months to <11 years) completed survey instruments reporting on the child's birth characteristics, reasons for cCMV testing, and present medical, developmental, and behavioral status. Latent Class Analysis was used to derive empirically driven groupings of outcomes, which we called ND Phenotypes. Chi-square analyses and t-tests examined the association between ND Phenotypes with child characteristics.

resultsFive ND Phenotypes were identified: 1) No sequelae with or without Isolated SNHL (n = 44, 18%), 2) High Medical and Neurodevelopmental Involvement (n = 31, 13%) 3) Some Developmental Delays with Mild Neuromuscular Involvement (n = 49, 20%) 4) Isolated Speech and Language Delays (n = 89, 37%) and 5) Autism and Global Developmental Delay (n = 29, 12%). ND Phenotype membership was predicted by birth characteristics and reason for cCMV testing.

conclusionFive ND Phenotypes of children with cCMV were identified. Future studies should examine stability of class membership over time. IMPACT: Five neurodevelopmental phenotypes of children with congenital cytomegalovirus were identified. All but one phenotype consisted of children with multiple long-term medical and neurodevelopmental sequelae. Physical findings, prematurity and intensive care admission at birth were associated with severity of outcome. Children tested for congenital cytomegalovirus due to a failed newborn hearing screen alone were most likely to have no long-term developmental delays.

Indexed as

Cytomegalovirus InfectionsDevelopmental DisabilitiesNeurodevelopmental DisordersChildChild DevelopmentChild, PreschoolCytomegalovirusFemaleHumansInfantInfant, NewbornMalePhenotype

Identifiers

PMID40925996
PMCPMC12751029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.